Nuevocor
Nuevocor is a IND-stage biotech focused on treating genetic cardiomyopathies by addressing their underlying mechanical defects
$45M Series B+ ·
Led by Angelini Ventures · Source: fundraisingfox.com
Total raised: $69M across 2 sourced rounds
All 2 rounds ↓Signals
Nuevocor | 135 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $45M | fundraisingfox.com | ||
| Series A | $24M | prnewswire.com |
Timeline
- Website created
Founders and team
BB
Brian Burke Co-Founder and Advisorsource: nuevocor.comCS
Colin Stewart Co-Founder and Advisorsource: nuevocor.comJJ
Jianming Jiang FounderMK
Mark Kay Co-Founder and AdvisorLinkedIn · source: nuevocor.comX(
XiangQian (XQ) Lin FounderYC
Yann Chong Tan FounderYL
Yin Loon Lee FounderAG
Albert Gianchetti CEOMR
Monica Ravindra Shah Chief Medical Officer
Investors
AAngelini Ventureslead investor
BBoehringer Ingelheim Venture Fundlead investor
CClavystBio
EEDBI
- EEVX Ventureslead investor
HHighlight Capital
KKurma Partnerslead investor
SSeeds Capital
XXora Innovation
Companies like Nuevocor
CCardiac Dimensions$53M Series B+ · Mar 2025
NNeurocarrus
SSRTD Biotech$35.26M Seed · Nov 2026
EEden Bio$1.17M Seed · Nov 2022HHugues & FilsPre Seed · Mar 2026
NNanobots Therapeutics$1.02M Pre Seed · Dec 2024
Other companies backed by Angelini Ventures
NNouscom$135.04M Series B+ · Oct 2026
MMMI$125M Series B+ · Oct 2026
RRougeTx$58M Series A · Oct 2026
AAptadir Therapeutics$45M Seed · Sep 2026
EEpicrispr Biotechnologies$90M Series B+ · Aug 2026
NNoctrix Health$33.5M Series B+ · Sep 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/nuevocor (get a free API key).